BRIDGE BIOTHERAPEUTICS, INC.

Press Releases Bridge Biotherapeutics, Inc.

Equities

A288330

KR7288330004

End-of-day quote Korea S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
2,220 ^KRW	+1.60%		-3.48%	-32.42%

03-28	Bridge Biotherapeutics Launches Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade	CI
03-26	Bridge Biotherapeutics Announces Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bridge Biotherapeutics to Present at the 2023 BIO International Convention	30/05/23	AQ
Bridge Biotherapeutics announces preclinical study of self-discovered 4th generation lung cancer targeted therapy at AACR conference in the US	16/03/23	AQ
Bridge Biotherapeutics : Material Management Information related to Judgment of Investment (US FDA approval of BBT-877 phase 2 clinical trial plan for the treatment of Idiopathic Pulmonary Fibrosis (IPF))	21/07/22	PU
Bridge Biotherapeutics : Organization of Investor Relations Event	18/07/22	PU
Bridge Biotherapeutics : Results of issuance(Voluntary Disclosure) (제3자배정-전환우선주)	31/05/22	PU
Bridge Biotherapeutics : Material Management Information related to Judgment of Investment (Bridge Biotherapeutics entered into a License agreement to acquire a preclinical asset to treat fibrotic diseases including Idiopathic Pulmonary Fibrosis (IPF))	19/04/22	PU
Bridge Biotherapeutics : Material Management Information related to Judgment of Investment (Bridge Biotherapeutics entered into an Option to License agreement to acquire a preclinical asset to treat fibrotic diseases including Idiopathic Pulmonary Fibrosis (IPF))	08/03/22	PU
Bridge Biotherapeutics : 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)	08/03/22	PU
Bridge Biotherapeutics : Resolutions for Convocation of General Meeting of Shareholders	08/03/22	PU
Bridge Biotherapeutics : Organization of Investor Relations Event	10/01/22	PU
Bridge Biotherapeutics : Organization of Investor Relations Event	22/12/21	PU
Bridge Biotherapeutics : Closure of Register of Shareholders or Designation of Record Date	07/12/21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer